We report a case of transient anti-HBs (antibodies to hepatitis B surface antigen) and anti-HBc (antibodies to hepatitis B core antigen) seropositivity following IVIg administration for GBS, despite negative pre-treatment serology and absence of hepatitis B infection. This evidence concerns the gene KRT88P and hepatitis B virus infection.